D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
$315M |
| 2 |
Exxon Mobil
XOM
|
$312M |
| 3 |
Verizon
VZ
|
$289M |
| 4 |
Procter & Gamble
PG
|
$288M |
| 5 |
Pfizer
PFE
|
$272M |
Top Sells
| 1 |
Tesla
TSLA
|
$619M |
| 2 |
Biogen
BIIB
|
$369M |
| 3 |
Amazon
AMZN
|
$341M |
| 4 |
Netflix
NFLX
|
$309M |
| 5 |
Emerson Electric
EMR
|
$306M |
Sector Composition
| 1 | Technology | 23.54% |
| 2 | Healthcare | 14.5% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Financials | 9.56% |
| 5 | Communication Services | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Henry Schein
HSIC
$8.22B
| $74.3M | 0.12% |
1,471,416
-697,213
| -32% | -$35.2M |
|
152
Edwards Lifesciences
EW
$47.5B
| $74.1M | 0.12% |
1,177,914
+1,040,259
| +756% | +$65.4M |
|
153
Ametek
AME
$43.4B
| $73M | 0.11% |
1,013,245
+522,629
| +107% | +$37.6M |
|
154
Invitation Homes
INVH
$18.6B
| $72.9M | 0.11% |
3,412,659
-803,280
| -19% | -$17.2M |
|
155
Gilead Sciences
GILD
$140B
| $72.4M | 0.11% |
968,435
-3,881,635
| -80% | -$290M |
|
|
ACIA
156
DELISTED
Acacia Communications, Inc. Common Stock
ACIA
| $71.5M | 0.11% |
1,064,957
-299,218
| -22% | -$20.1M |
|
|
AVLR
157
DELISTED
Avalara, Inc.
AVLR
| $71.3M | 0.11% |
955,986
-275,805
| -22% | -$20.6M |
|
158
Elanco Animal Health
ELAN
$8.68B
| $71.2M | 0.11% |
3,178,969
+18,627
| +0.6% | +$417K |
|
159
Southern Company
SO
$101B
| $71M | 0.11% |
1,311,350
+1,062,929
| +428% | +$57.5M |
|
160
Vertex Pharmaceuticals
VRTX
$102B
| $70.7M | 0.11% |
297,187
-76,786
| -21% | -$18.3M |
|
|
IAA
161
DELISTED
IAA, Inc. Common Stock
IAA
| $70.3M | 0.11% |
2,345,994
-215,336
| -8% | -$6.45M |
|
162
NetApp
NTAP
$23.7B
| $70M | 0.11% |
1,679,047
-46,932
| -3% | -$1.96M |
|
163
Waste Management
WM
$90.6B
| $69.3M | 0.11% |
748,673
+221,468
| +42% | +$20.5M |
|
164
Fidelity National Financial
FNF
$16.4B
| $69.2M | 0.11% |
2,894,052
+1,840,525
| +175% | +$44M |
|
165
Schrodinger
SDGR
$1.4B
| $69M | 0.11% |
+1,601,047
| New | +$69M |
|
|
ZNGA
166
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $68.9M | 0.11% |
10,056,885
+718,793
| +8% | +$4.92M |
|
167
Trimble
TRMB
$19B
| $68.6M | 0.11% |
2,154,622
-57,804
| -3% | -$1.84M |
|
168
Teladoc Health
TDOC
$1.35B
| $68.4M | 0.11% |
+441,179
| New | +$68.4M |
|
|
RTN
169
DELISTED
Raytheon Company
RTN
| $68.2M | 0.11% |
519,901
-159,024
| -23% | -$20.9M |
|
|
UN
170
DELISTED
Unilever NV New York Registry Shares
UN
| $68M | 0.11% |
+1,394,595
| New | +$68M |
|
171
Qorvo
QRVO
$8.54B
| $67.8M | 0.11% |
841,357
-741,747
| -47% | -$59.8M |
|
|
JNPR
172
DELISTED
Juniper Networks
JNPR
| $67.1M | 0.1% |
3,505,664
-814,485
| -19% | -$15.6M |
|
173
Trip.com Group
TCOM
$47.7B
| $66.7M | 0.1% |
2,843,723
+807,108
| +40% | +$18.9M |
|
174
Utilities Select Sector SPDR Fund
XLU
$20.8B
| $66.5M | 0.1% |
+1,200,000
| New | +$66.5M |
|
|
ALXN
175
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $66.1M | 0.1% |
736,153
-148,056
| -17% | -$13.3M |
|